Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinopathy of Prematurity | 44 | 2023 | 421 | 10.070 |
Why?
|
Electroretinography | 82 | 2023 | 509 | 8.140 |
Why?
|
Retinal Rod Photoreceptor Cells | 35 | 2016 | 195 | 7.240 |
Why?
|
Dark Adaptation | 69 | 2019 | 219 | 6.290 |
Why?
|
Retina | 58 | 2023 | 2616 | 3.830 |
Why?
|
Retinal Cone Photoreceptor Cells | 13 | 2020 | 177 | 3.490 |
Why?
|
Retinoschisis | 6 | 2023 | 30 | 3.180 |
Why?
|
Myopia | 12 | 2023 | 254 | 2.870 |
Why?
|
Refractive Errors | 9 | 2023 | 142 | 2.610 |
Why?
|
Sensory Thresholds | 33 | 2016 | 391 | 2.570 |
Why?
|
Vision, Ocular | 23 | 2021 | 464 | 2.400 |
Why?
|
Fovea Centralis | 11 | 2022 | 119 | 2.330 |
Why?
|
Visual Acuity | 44 | 2023 | 2530 | 2.250 |
Why?
|
Retinal Degeneration | 15 | 2017 | 415 | 1.800 |
Why?
|
Retinal Diseases | 13 | 2023 | 683 | 1.780 |
Why?
|
Photoreceptor Cells, Vertebrate | 6 | 2019 | 204 | 1.510 |
Why?
|
Night Blindness | 4 | 2019 | 53 | 1.440 |
Why?
|
Hyperopia | 5 | 2023 | 44 | 1.400 |
Why?
|
Retinitis Pigmentosa | 7 | 2023 | 386 | 1.380 |
Why?
|
Visual Fields | 12 | 2019 | 1047 | 1.380 |
Why?
|
Retinal Vessels | 10 | 2021 | 772 | 1.370 |
Why?
|
Eye | 10 | 2023 | 729 | 1.360 |
Why?
|
Vigabatrin | 3 | 2015 | 92 | 1.230 |
Why?
|
Macular Degeneration | 3 | 2021 | 980 | 1.210 |
Why?
|
Tomography, Optical Coherence | 9 | 2022 | 2657 | 1.130 |
Why?
|
Photic Stimulation | 27 | 2019 | 2025 | 1.110 |
Why?
|
Photophobia | 4 | 2019 | 67 | 1.100 |
Why?
|
Visual Field Tests | 7 | 2021 | 383 | 1.040 |
Why?
|
Retinal Neovascularization | 4 | 2013 | 244 | 0.970 |
Why?
|
Rhodopsin | 17 | 2009 | 203 | 0.960 |
Why?
|
Evoked Potentials, Visual | 10 | 2021 | 427 | 0.950 |
Why?
|
Ophthalmoscopy | 6 | 2020 | 176 | 0.940 |
Why?
|
Infant, Newborn | 61 | 2023 | 25625 | 0.920 |
Why?
|
Eye Diseases, Hereditary | 3 | 2019 | 117 | 0.910 |
Why?
|
Color Vision | 2 | 2019 | 21 | 0.880 |
Why?
|
Choroid Diseases | 1 | 2023 | 66 | 0.860 |
Why?
|
Visual Perception | 10 | 2014 | 1420 | 0.860 |
Why?
|
Infant | 86 | 2023 | 35136 | 0.850 |
Why?
|
Adaptation, Ocular | 11 | 2008 | 93 | 0.840 |
Why?
|
Esotropia | 5 | 2018 | 91 | 0.840 |
Why?
|
Refraction, Ocular | 9 | 2023 | 182 | 0.830 |
Why?
|
Leber Congenital Amaurosis | 3 | 2017 | 33 | 0.820 |
Why?
|
Corneal Dystrophies, Hereditary | 1 | 2023 | 81 | 0.810 |
Why?
|
Contact Lenses | 1 | 2023 | 145 | 0.800 |
Why?
|
Retinal Dystrophies | 1 | 2021 | 58 | 0.750 |
Why?
|
Genetic Diseases, X-Linked | 3 | 2019 | 372 | 0.750 |
Why?
|
Photoreceptor Cells | 15 | 1996 | 244 | 0.720 |
Why?
|
Albinism, Ocular | 2 | 2017 | 8 | 0.710 |
Why?
|
Choroideremia | 1 | 2019 | 25 | 0.690 |
Why?
|
Retinal Ganglion Cells | 3 | 2019 | 770 | 0.670 |
Why?
|
Disease Models, Animal | 17 | 2016 | 18029 | 0.670 |
Why?
|
Retinal Pigments | 11 | 2002 | 83 | 0.670 |
Why?
|
Child | 75 | 2023 | 77709 | 0.660 |
Why?
|
Microcephaly | 1 | 2023 | 432 | 0.660 |
Why?
|
Eye Proteins | 5 | 2023 | 646 | 0.650 |
Why?
|
Macula Lutea | 5 | 2017 | 151 | 0.640 |
Why?
|
Exotropia | 1 | 2018 | 55 | 0.640 |
Why?
|
Anticonvulsants | 3 | 2015 | 1916 | 0.630 |
Why?
|
Albinism | 3 | 2021 | 25 | 0.620 |
Why?
|
Gestational Age | 12 | 2023 | 3493 | 0.620 |
Why?
|
Vitelliform Macular Dystrophy | 1 | 2017 | 12 | 0.600 |
Why?
|
Psychophysics | 17 | 2019 | 309 | 0.600 |
Why?
|
Smith-Lemli-Opitz Syndrome | 2 | 2010 | 46 | 0.600 |
Why?
|
Hemianopsia | 1 | 2018 | 122 | 0.600 |
Why?
|
Oxygen | 13 | 2016 | 4189 | 0.580 |
Why?
|
Infant, Premature | 7 | 2017 | 2044 | 0.570 |
Why?
|
Albinism, Oculocutaneous | 4 | 2022 | 17 | 0.570 |
Why?
|
Ophthalmology | 2 | 2021 | 508 | 0.550 |
Why?
|
Vision Disorders | 12 | 2021 | 1058 | 0.550 |
Why?
|
Encephalocele | 1 | 2017 | 136 | 0.540 |
Why?
|
Rats | 36 | 2016 | 24260 | 0.530 |
Why?
|
Thalamus | 2 | 2019 | 1023 | 0.530 |
Why?
|
Child, Preschool | 63 | 2022 | 41006 | 0.520 |
Why?
|
Rats, Sprague-Dawley | 19 | 2016 | 8301 | 0.500 |
Why?
|
Adolescent | 65 | 2022 | 85781 | 0.490 |
Why?
|
Humans | 192 | 2023 | 744343 | 0.480 |
Why?
|
Migraine Disorders | 4 | 2019 | 1620 | 0.480 |
Why?
|
Mydriatics | 4 | 2022 | 68 | 0.480 |
Why?
|
Retinal Pigment Epithelium | 2 | 2015 | 302 | 0.480 |
Why?
|
Animals, Newborn | 15 | 2016 | 2726 | 0.480 |
Why?
|
Anterior Eye Segment | 2 | 2022 | 152 | 0.470 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2013 | 22 | 0.460 |
Why?
|
Blood Coagulation Disorders, Inherited | 1 | 2013 | 18 | 0.460 |
Why?
|
Blindness, Cortical | 2 | 2005 | 18 | 0.460 |
Why?
|
Bardet-Biedl Syndrome | 5 | 2007 | 42 | 0.450 |
Why?
|
Eye Abnormalities | 3 | 2021 | 246 | 0.450 |
Why?
|
Glaucoma | 2 | 2023 | 1159 | 0.450 |
Why?
|
Term Birth | 2 | 2015 | 135 | 0.450 |
Why?
|
Ophthalmoscopes | 1 | 2012 | 23 | 0.450 |
Why?
|
Retinal Artery | 3 | 2013 | 111 | 0.440 |
Why?
|
Retinal Detachment | 1 | 2017 | 411 | 0.430 |
Why?
|
Diabetic Retinopathy | 1 | 2021 | 1210 | 0.410 |
Why?
|
Vision Tests | 13 | 2005 | 167 | 0.400 |
Why?
|
Laser Coagulation | 3 | 2023 | 326 | 0.400 |
Why?
|
Amino Acid Transport Systems, Neutral | 2 | 2022 | 41 | 0.400 |
Why?
|
Intravitreal Injections | 2 | 2023 | 344 | 0.390 |
Why?
|
Optic Disk | 2 | 2022 | 400 | 0.390 |
Why?
|
Optic Atrophies, Hereditary | 6 | 2011 | 27 | 0.380 |
Why?
|
Arterioles | 3 | 2013 | 254 | 0.380 |
Why?
|
Pigment Epithelium of Eye | 7 | 1999 | 220 | 0.360 |
Why?
|
Fourier Analysis | 2 | 2008 | 447 | 0.360 |
Why?
|
Blindness | 6 | 2016 | 617 | 0.350 |
Why?
|
Light | 13 | 2018 | 1374 | 0.350 |
Why?
|
Rod Cell Outer Segment | 6 | 1999 | 56 | 0.340 |
Why?
|
Deferoxamine | 2 | 2007 | 151 | 0.330 |
Why?
|
Color Vision Defects | 1 | 2008 | 28 | 0.330 |
Why?
|
Ocular Physiological Phenomena | 2 | 2005 | 70 | 0.330 |
Why?
|
Neural Pathways | 2 | 2019 | 2972 | 0.330 |
Why?
|
Eye Diseases | 10 | 2014 | 669 | 0.330 |
Why?
|
Intracranial Hypertension | 2 | 2022 | 186 | 0.320 |
Why?
|
Adult | 71 | 2023 | 214055 | 0.320 |
Why?
|
Retinal Vein | 2 | 2005 | 47 | 0.310 |
Why?
|
Alagille Syndrome | 1 | 2007 | 35 | 0.310 |
Why?
|
Siderophores | 1 | 2007 | 57 | 0.300 |
Why?
|
Visual Pathways | 5 | 2021 | 565 | 0.290 |
Why?
|
Membrane Proteins | 6 | 2021 | 7880 | 0.280 |
Why?
|
Child Development | 6 | 2009 | 2223 | 0.280 |
Why?
|
Methylmalonic Acid | 2 | 2005 | 49 | 0.280 |
Why?
|
Scotoma | 1 | 2007 | 139 | 0.280 |
Why?
|
Aging | 20 | 2010 | 8664 | 0.280 |
Why?
|
Pupil | 3 | 2001 | 149 | 0.270 |
Why?
|
Animals | 47 | 2023 | 168757 | 0.270 |
Why?
|
Usher Syndromes | 2 | 2021 | 50 | 0.260 |
Why?
|
Homocystinuria | 2 | 2005 | 67 | 0.260 |
Why?
|
Cyclopentolate | 2 | 2001 | 6 | 0.260 |
Why?
|
Electrophysiology | 4 | 2018 | 1308 | 0.260 |
Why?
|
Amblyopia | 7 | 1988 | 143 | 0.250 |
Why?
|
Vision, Low | 2 | 2021 | 168 | 0.250 |
Why?
|
Visually Impaired Persons | 1 | 2005 | 81 | 0.250 |
Why?
|
Lasers | 2 | 2023 | 952 | 0.240 |
Why?
|
Electrooculography | 2 | 2018 | 118 | 0.240 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2005 | 116 | 0.240 |
Why?
|
Oscillometry | 4 | 2008 | 147 | 0.240 |
Why?
|
Tiletamine | 1 | 2003 | 2 | 0.240 |
Why?
|
Zolazepam | 1 | 2003 | 2 | 0.240 |
Why?
|
Light Signal Transduction | 1 | 2023 | 29 | 0.230 |
Why?
|
Fundus Oculi | 2 | 2002 | 473 | 0.230 |
Why?
|
Male | 57 | 2023 | 350118 | 0.220 |
Why?
|
Electrodes | 2 | 2008 | 619 | 0.220 |
Why?
|
Pentobarbital | 1 | 2003 | 155 | 0.220 |
Why?
|
Laurence-Moon Syndrome | 3 | 1993 | 8 | 0.220 |
Why?
|
Anesthetics, Dissociative | 1 | 2003 | 80 | 0.220 |
Why?
|
Young Adult | 16 | 2022 | 56430 | 0.220 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5708 | 0.210 |
Why?
|
Fluorescein Angiography | 3 | 2021 | 940 | 0.210 |
Why?
|
Angiogenesis Inhibitors | 2 | 2023 | 2038 | 0.210 |
Why?
|
Galvanic Skin Response | 1 | 2004 | 349 | 0.210 |
Why?
|
Optic Atrophy, Hereditary, Leber | 3 | 2009 | 46 | 0.210 |
Why?
|
Female | 56 | 2022 | 380194 | 0.210 |
Why?
|
Cyclic GMP | 1 | 2023 | 409 | 0.210 |
Why?
|
Nerve Growth Factor | 1 | 2023 | 149 | 0.200 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2005 | 333 | 0.200 |
Why?
|
Nystagmus, Congenital | 1 | 2021 | 7 | 0.200 |
Why?
|
Retinal Neurons | 2 | 2013 | 66 | 0.200 |
Why?
|
Optic Nerve Diseases | 4 | 2019 | 327 | 0.200 |
Why?
|
Pseudotumor Cerebri | 1 | 2022 | 100 | 0.200 |
Why?
|
beta-Thalassemia | 2 | 2007 | 225 | 0.200 |
Why?
|
Administration, Topical | 1 | 2023 | 690 | 0.190 |
Why?
|
Nerve Tissue Proteins | 2 | 2013 | 4462 | 0.190 |
Why?
|
Neurons | 3 | 2016 | 9338 | 0.190 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2005 | 719 | 0.180 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2020 | 95 | 0.180 |
Why?
|
Vestibular Diseases | 1 | 2023 | 217 | 0.180 |
Why?
|
Night Vision | 1 | 2019 | 6 | 0.180 |
Why?
|
Rats, Long-Evans | 3 | 2016 | 387 | 0.180 |
Why?
|
Phenotype | 8 | 2023 | 16365 | 0.180 |
Why?
|
cis-trans-Isomerases | 3 | 2016 | 44 | 0.180 |
Why?
|
Nystagmus, Pathologic | 2 | 2017 | 96 | 0.180 |
Why?
|
Premature Birth | 4 | 2015 | 1721 | 0.180 |
Why?
|
Microtubule-Associated Proteins | 3 | 2023 | 1086 | 0.170 |
Why?
|
Muscle Hypotonia | 1 | 2020 | 165 | 0.170 |
Why?
|
Rod Opsins | 4 | 2008 | 111 | 0.170 |
Why?
|
Ischemia | 1 | 2008 | 1907 | 0.170 |
Why?
|
Fixation, Ocular | 3 | 2019 | 251 | 0.170 |
Why?
|
Photography | 1 | 2002 | 520 | 0.170 |
Why?
|
Mitochondrial Diseases | 1 | 2002 | 320 | 0.160 |
Why?
|
Astigmatism | 5 | 2021 | 69 | 0.160 |
Why?
|
Cornea | 3 | 2015 | 1524 | 0.160 |
Why?
|
Infant, Premature, Diseases | 4 | 2013 | 706 | 0.160 |
Why?
|
Aconitate Hydratase | 1 | 2017 | 15 | 0.150 |
Why?
|
Gene Duplication | 1 | 1999 | 329 | 0.150 |
Why?
|
Color Perception | 1 | 2018 | 213 | 0.150 |
Why?
|
Spasms, Infantile | 1 | 2021 | 305 | 0.150 |
Why?
|
Electrodiagnosis | 1 | 2018 | 151 | 0.150 |
Why?
|
Cell Adhesion Molecules | 1 | 2023 | 1602 | 0.150 |
Why?
|
Mutation | 13 | 2023 | 29786 | 0.150 |
Why?
|
Lens, Crystalline | 3 | 2015 | 388 | 0.140 |
Why?
|
Abnormalities, Multiple | 3 | 2023 | 1416 | 0.140 |
Why?
|
Retinal Vein Occlusion | 1 | 1997 | 137 | 0.140 |
Why?
|
Nephrosis | 1 | 2016 | 45 | 0.140 |
Why?
|
Calcium Channels, L-Type | 1 | 2017 | 240 | 0.140 |
Why?
|
Optic Nerve | 1 | 2019 | 554 | 0.130 |
Why?
|
Cell Count | 2 | 2016 | 1856 | 0.130 |
Why?
|
Hypnotics and Sedatives | 1 | 2003 | 1162 | 0.130 |
Why?
|
Acetazolamide | 1 | 1995 | 100 | 0.130 |
Why?
|
Ataxia | 1 | 2017 | 304 | 0.130 |
Why?
|
Craniosynostoses | 1 | 2019 | 401 | 0.130 |
Why?
|
Hyperoxia | 2 | 2007 | 262 | 0.120 |
Why?
|
Cell Shape | 1 | 2016 | 375 | 0.120 |
Why?
|
Retrospective Studies | 9 | 2023 | 77449 | 0.120 |
Why?
|
Nystagmus, Optokinetic | 1 | 1994 | 31 | 0.120 |
Why?
|
Developmental Disabilities | 3 | 2020 | 1456 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2915 | 0.120 |
Why?
|
Visual Cortex | 3 | 2019 | 1149 | 0.120 |
Why?
|
Persistent Hyperplastic Primary Vitreous | 1 | 2013 | 7 | 0.120 |
Why?
|
Disease Progression | 4 | 2017 | 13284 | 0.120 |
Why?
|
Retinal Bipolar Cells | 2 | 2016 | 47 | 0.120 |
Why?
|
Epilepsy | 1 | 2009 | 3310 | 0.110 |
Why?
|
Oxidoreductases | 2 | 2008 | 424 | 0.110 |
Why?
|
Halothane | 1 | 1992 | 206 | 0.110 |
Why?
|
Point Mutation | 1 | 2017 | 1623 | 0.100 |
Why?
|
Family | 1 | 2023 | 3147 | 0.100 |
Why?
|
Nystagmus, Physiologic | 2 | 2009 | 29 | 0.100 |
Why?
|
Vision Screening | 1 | 1992 | 66 | 0.100 |
Why?
|
Biometry | 1 | 2015 | 558 | 0.100 |
Why?
|
Membrane Transport Proteins | 2 | 2008 | 1028 | 0.100 |
Why?
|
Cohort Studies | 5 | 2023 | 40561 | 0.100 |
Why?
|
Birth Weight | 3 | 2010 | 2069 | 0.090 |
Why?
|
Occlusive Dressings | 2 | 1988 | 50 | 0.090 |
Why?
|
Frameshift Mutation | 3 | 2017 | 399 | 0.090 |
Why?
|
Genotype | 5 | 2023 | 12951 | 0.090 |
Why?
|
Space Perception | 1 | 1994 | 475 | 0.090 |
Why?
|
Hereditary Sensory and Motor Neuropathy | 1 | 1990 | 21 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1257 | 0.090 |
Why?
|
Carrier Proteins | 3 | 2016 | 5021 | 0.090 |
Why?
|
Mice, Knockout | 2 | 2023 | 14557 | 0.090 |
Why?
|
Blotting, Western | 2 | 2015 | 5179 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.090 |
Why?
|
Syndrome | 6 | 2022 | 3251 | 0.090 |
Why?
|
Functional Laterality | 2 | 2016 | 2290 | 0.090 |
Why?
|
Reference Values | 5 | 2003 | 4982 | 0.090 |
Why?
|
Choroid | 2 | 1991 | 322 | 0.090 |
Why?
|
Injections, Intraperitoneal | 1 | 2010 | 425 | 0.090 |
Why?
|
Hydrocephalus | 1 | 2016 | 748 | 0.090 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2011 | 249 | 0.090 |
Why?
|
DNA | 3 | 2022 | 7301 | 0.090 |
Why?
|
Medical Records | 2 | 2010 | 1413 | 0.080 |
Why?
|
Strabismus | 5 | 1988 | 287 | 0.080 |
Why?
|
Middle Aged | 20 | 2022 | 213383 | 0.080 |
Why?
|
Kinetics | 3 | 2005 | 6473 | 0.080 |
Why?
|
Acetamides | 1 | 2010 | 249 | 0.080 |
Why?
|
Hyperprolactinemia | 1 | 1989 | 129 | 0.080 |
Why?
|
DNA Mutational Analysis | 5 | 2022 | 4186 | 0.080 |
Why?
|
Carotenoids | 1 | 2011 | 624 | 0.080 |
Why?
|
Adaptation, Physiological | 3 | 1988 | 1312 | 0.080 |
Why?
|
Eye Movements | 3 | 1987 | 507 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2214 | 0.080 |
Why?
|
Language | 1 | 2016 | 1471 | 0.070 |
Why?
|
Cognition | 2 | 2023 | 6770 | 0.070 |
Why?
|
Genetic Testing | 3 | 2017 | 3444 | 0.070 |
Why?
|
Densitometry | 5 | 1988 | 156 | 0.070 |
Why?
|
Hydroxocobalamin | 2 | 2005 | 31 | 0.070 |
Why?
|
Dopamine | 1 | 2013 | 1591 | 0.070 |
Why?
|
Apraxias | 1 | 1987 | 64 | 0.070 |
Why?
|
Signal Transduction | 4 | 2013 | 23403 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 1813 | 0.070 |
Why?
|
Age Factors | 17 | 2009 | 18370 | 0.070 |
Why?
|
Venules | 1 | 2006 | 165 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3597 | 0.070 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 2 | 2005 | 255 | 0.070 |
Why?
|
Cobamides | 1 | 2005 | 12 | 0.070 |
Why?
|
Proteins | 5 | 2016 | 6103 | 0.070 |
Why?
|
Ophthalmoplegia | 1 | 1987 | 166 | 0.070 |
Why?
|
Betaine | 1 | 2005 | 87 | 0.060 |
Why?
|
Saccades | 1 | 1987 | 246 | 0.060 |
Why?
|
Pedigree | 6 | 2016 | 4644 | 0.060 |
Why?
|
Receptor, Notch1 | 1 | 2007 | 502 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3610 | 0.060 |
Why?
|
Professional Practice | 1 | 2006 | 326 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3582 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.060 |
Why?
|
Chromosomes, Human, X | 1 | 2006 | 296 | 0.060 |
Why?
|
Pigmentation Disorders | 2 | 1982 | 101 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2703 | 0.060 |
Why?
|
Methionine | 2 | 2005 | 590 | 0.060 |
Why?
|
Photometry | 3 | 1991 | 58 | 0.060 |
Why?
|
Metabolism, Inborn Errors | 1 | 2006 | 288 | 0.060 |
Why?
|
Infant, Low Birth Weight | 1 | 2008 | 850 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7913 | 0.060 |
Why?
|
Time Factors | 11 | 2010 | 40075 | 0.060 |
Why?
|
Prospective Studies | 3 | 2023 | 53288 | 0.060 |
Why?
|
Cytoskeletal Proteins | 2 | 2021 | 1364 | 0.050 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1081 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2013 | 13033 | 0.050 |
Why?
|
Microspectrophotometry | 2 | 1999 | 4 | 0.050 |
Why?
|
Pediatrics | 2 | 2006 | 3475 | 0.050 |
Why?
|
Homocysteine | 1 | 2005 | 647 | 0.050 |
Why?
|
Prevalence | 1 | 2018 | 15226 | 0.050 |
Why?
|
Mice | 7 | 2023 | 81183 | 0.050 |
Why?
|
Area Under Curve | 1 | 2005 | 1654 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1622 | 0.050 |
Why?
|
Mitochondria, Muscle | 1 | 2002 | 171 | 0.050 |
Why?
|
Conserved Sequence | 2 | 2003 | 1202 | 0.050 |
Why?
|
Cholesterol | 1 | 2010 | 2917 | 0.050 |
Why?
|
Phenylacetates | 1 | 1980 | 114 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 1997 | 4584 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7279 | 0.050 |
Why?
|
Chromosomes, Human, 16-18 | 1 | 1980 | 32 | 0.050 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2020 | 230 | 0.050 |
Why?
|
Ligands | 1 | 2007 | 3282 | 0.050 |
Why?
|
Histone Demethylases | 1 | 2023 | 321 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1676 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 14722 | 0.040 |
Why?
|
Chickens | 1 | 1982 | 865 | 0.040 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2001 | 354 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3617 | 0.040 |
Why?
|
Homozygote | 2 | 2020 | 1785 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2009 | 5078 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 1 | 2020 | 496 | 0.040 |
Why?
|
Vitamin A | 1 | 1982 | 615 | 0.040 |
Why?
|
Recovery of Function | 1 | 2009 | 2925 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2011 | 3297 | 0.040 |
Why?
|
Haplorhini | 1 | 1999 | 552 | 0.040 |
Why?
|
Trisomy | 1 | 1980 | 266 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2010 | 15540 | 0.040 |
Why?
|
Urodela | 1 | 1978 | 17 | 0.040 |
Why?
|
Deer | 1 | 1977 | 14 | 0.040 |
Why?
|
Drug Combinations | 1 | 2003 | 1959 | 0.040 |
Why?
|
Anophthalmos | 1 | 1977 | 22 | 0.040 |
Why?
|
ROC Curve | 1 | 2005 | 3527 | 0.040 |
Why?
|
Phagosomes | 1 | 1999 | 193 | 0.040 |
Why?
|
Glaucoma, Neovascular | 1 | 1997 | 36 | 0.040 |
Why?
|
Cystic Fibrosis | 2 | 1985 | 1177 | 0.040 |
Why?
|
Polyploidy | 1 | 1977 | 114 | 0.040 |
Why?
|
Brain | 3 | 2017 | 26385 | 0.040 |
Why?
|
Microphthalmos | 1 | 1977 | 54 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2008 | 3768 | 0.040 |
Why?
|
International Agencies | 1 | 2018 | 240 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2002 | 817 | 0.040 |
Why?
|
Prognosis | 2 | 2015 | 29063 | 0.040 |
Why?
|
Attention | 2 | 1987 | 2400 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 3508 | 0.040 |
Why?
|
Eye Manifestations | 1 | 1976 | 11 | 0.040 |
Why?
|
Differential Threshold | 2 | 1992 | 80 | 0.040 |
Why?
|
Cryosurgery | 2 | 1995 | 453 | 0.040 |
Why?
|
Mathematical Concepts | 1 | 2016 | 63 | 0.040 |
Why?
|
Heterozygote | 1 | 2003 | 2804 | 0.030 |
Why?
|
Chelating Agents | 1 | 1998 | 380 | 0.030 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 25043 | 0.030 |
Why?
|
Calibration | 2 | 2008 | 816 | 0.030 |
Why?
|
Coloboma | 2 | 1991 | 54 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2020 | 1401 | 0.030 |
Why?
|
Exons | 2 | 1999 | 2437 | 0.030 |
Why?
|
Acute Disease | 3 | 2001 | 7149 | 0.030 |
Why?
|
Aerobiosis | 1 | 1995 | 106 | 0.030 |
Why?
|
Axial Length, Eye | 1 | 2015 | 31 | 0.030 |
Why?
|
Posterior Eye Segment | 1 | 2015 | 14 | 0.030 |
Why?
|
Nerve Fibers | 1 | 2019 | 687 | 0.030 |
Why?
|
Age Distribution | 1 | 2001 | 2902 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1999 | 1799 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 2020 | 4740 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12072 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 1977 | 514 | 0.030 |
Why?
|
Laser Therapy | 2 | 1995 | 1072 | 0.030 |
Why?
|
Anterior Chamber | 1 | 2015 | 197 | 0.030 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2013 | 64 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2649 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2018 | 21746 | 0.030 |
Why?
|
Retinoscopy | 1 | 2013 | 27 | 0.030 |
Why?
|
Problem Solving | 1 | 2016 | 440 | 0.030 |
Why?
|
Cattle | 1 | 1999 | 3922 | 0.030 |
Why?
|
Music | 1 | 2016 | 263 | 0.030 |
Why?
|
Spectrophotometry | 2 | 1990 | 313 | 0.030 |
Why?
|
Child Health Services | 1 | 1979 | 667 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2016 | 35421 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2014 | 19905 | 0.030 |
Why?
|
Aspartic Acid | 1 | 1995 | 576 | 0.030 |
Why?
|
Conjunctiva | 1 | 1976 | 494 | 0.030 |
Why?
|
Polysomnography | 1 | 2019 | 1776 | 0.030 |
Why?
|
Giant Cell Arteritis | 1 | 1976 | 292 | 0.030 |
Why?
|
Chediak-Higashi Syndrome | 1 | 1992 | 9 | 0.030 |
Why?
|
Down Syndrome | 1 | 2020 | 880 | 0.030 |
Why?
|
Mutation, Missense | 2 | 2017 | 2564 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2001 | 2421 | 0.030 |
Why?
|
Trans-Activators | 1 | 2001 | 2924 | 0.030 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 2002 | 335 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2001 | 1703 | 0.030 |
Why?
|
Intraocular Pressure | 1 | 1997 | 1270 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 29144 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10638 | 0.020 |
Why?
|
Aged | 9 | 2022 | 163280 | 0.020 |
Why?
|
Rats, Mutant Strains | 1 | 1991 | 70 | 0.020 |
Why?
|
Blood Transfusion | 1 | 1998 | 1301 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1977 | 1813 | 0.020 |
Why?
|
Sarcoidosis | 1 | 1976 | 506 | 0.020 |
Why?
|
Random Allocation | 1 | 1995 | 2429 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2010 | 13989 | 0.020 |
Why?
|
Rats, Inbred Strains | 4 | 1987 | 2186 | 0.020 |
Why?
|
Uveal Diseases | 2 | 1987 | 45 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2011 | 323 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 1572 | 0.020 |
Why?
|
Neural Inhibition | 1 | 1994 | 602 | 0.020 |
Why?
|
Melanins | 1 | 1992 | 289 | 0.020 |
Why?
|
Pattern Recognition, Visual | 2 | 1986 | 824 | 0.020 |
Why?
|
Iron | 1 | 1998 | 1774 | 0.020 |
Why?
|
Kidney Diseases, Cystic | 1 | 2011 | 186 | 0.020 |
Why?
|
Choroid Neoplasms | 2 | 1980 | 175 | 0.020 |
Why?
|
Massachusetts | 1 | 2001 | 8663 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2005 | 8949 | 0.020 |
Why?
|
Models, Biological | 1 | 2005 | 9583 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 2003 | 18111 | 0.020 |
Why?
|
Genes, Recessive | 2 | 2003 | 641 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 1976 | 1170 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 1997 | 2046 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39050 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2008 | 209 | 0.020 |
Why?
|
Cranial Nerve Neoplasms | 1 | 1988 | 129 | 0.020 |
Why?
|
Microscopy, Electron | 3 | 1982 | 2645 | 0.020 |
Why?
|
Spinocerebellar Degenerations | 1 | 1987 | 43 | 0.020 |
Why?
|
Vitamin E Deficiency | 1 | 1987 | 32 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1988 | 683 | 0.020 |
Why?
|
Prolactin | 1 | 1989 | 669 | 0.020 |
Why?
|
Contrast Sensitivity | 1 | 1988 | 244 | 0.020 |
Why?
|
Cataract | 3 | 1985 | 834 | 0.020 |
Why?
|
Mathematics | 1 | 1988 | 728 | 0.020 |
Why?
|
Oligodendroglioma | 1 | 1988 | 279 | 0.020 |
Why?
|
Memory | 1 | 2016 | 2174 | 0.020 |
Why?
|
Injections | 1 | 2009 | 840 | 0.020 |
Why?
|
Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2006 | 19 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3743 | 0.020 |
Why?
|
Eye Neoplasms | 2 | 1978 | 313 | 0.020 |
Why?
|
Craniopharyngioma | 1 | 1988 | 281 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2916 | 0.020 |
Why?
|
Face | 2 | 1984 | 994 | 0.020 |
Why?
|
Language Development Disorders | 1 | 1987 | 196 | 0.020 |
Why?
|
Amino Acids, Sulfur | 1 | 1984 | 16 | 0.020 |
Why?
|
Linear Models | 1 | 1995 | 5952 | 0.020 |
Why?
|
Safety | 1 | 2009 | 1186 | 0.020 |
Why?
|
Malonates | 1 | 1984 | 42 | 0.020 |
Why?
|
Dependovirus | 1 | 2009 | 706 | 0.020 |
Why?
|
Photolysis | 1 | 1984 | 92 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2008 | 57776 | 0.020 |
Why?
|
Fetus | 1 | 1991 | 1880 | 0.010 |
Why?
|
Cholestasis | 1 | 1987 | 378 | 0.010 |
Why?
|
Referral and Consultation | 2 | 2006 | 3528 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 6993 | 0.010 |
Why?
|
Form Perception | 1 | 1984 | 182 | 0.010 |
Why?
|
Rodent Diseases | 1 | 1983 | 57 | 0.010 |
Why?
|
Evolution, Molecular | 2 | 2003 | 1940 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2008 | 1462 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 21827 | 0.010 |
Why?
|
Regeneration | 2 | 1988 | 1485 | 0.010 |
Why?
|
Vitamin E | 1 | 1987 | 869 | 0.010 |
Why?
|
Incidence | 1 | 2001 | 20947 | 0.010 |
Why?
|
Psychophysiology | 1 | 1982 | 135 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2373 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4803 | 0.010 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2003 | 417 | 0.010 |
Why?
|
Algorithms | 1 | 2002 | 13881 | 0.010 |
Why?
|
Occupational Diseases | 2 | 1980 | 1471 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 2 | 1982 | 964 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2008 | 1547 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1984 | 527 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 1985 | 748 | 0.010 |
Why?
|
Action Potentials | 2 | 1978 | 1806 | 0.010 |
Why?
|
Brain Diseases | 2 | 1987 | 1563 | 0.010 |
Why?
|
Tuberous Sclerosis | 1 | 1988 | 1029 | 0.010 |
Why?
|
Chemical Industry | 1 | 1980 | 114 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2009 | 3420 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2003 | 13815 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 1988 | 1345 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3778 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 1985 | 1178 | 0.010 |
Why?
|
Reaction Time | 1 | 1985 | 2097 | 0.010 |
Why?
|
Regression Analysis | 1 | 1988 | 6459 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1982 | 1866 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2839 | 0.010 |
Why?
|
Gene Deletion | 1 | 2006 | 2751 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2011 | 12026 | 0.010 |
Why?
|
Optic Atrophy | 1 | 1977 | 79 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10943 | 0.010 |
Why?
|
Base Sequence | 1 | 2008 | 12797 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9438 | 0.010 |
Why?
|
Iris | 1 | 1977 | 239 | 0.010 |
Why?
|
Pyloric Antrum | 1 | 1976 | 69 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2892 | 0.010 |
Why?
|
Meningoencephalitis | 1 | 1976 | 78 | 0.010 |
Why?
|
Haplotypes | 1 | 2003 | 2779 | 0.010 |
Why?
|
Blood Sedimentation | 1 | 1976 | 231 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2006 | 2266 | 0.010 |
Why?
|
Choristoma | 1 | 1977 | 213 | 0.010 |
Why?
|
Temporal Arteries | 1 | 1976 | 128 | 0.010 |
Why?
|
Eyelids | 1 | 1977 | 265 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3760 | 0.010 |
Why?
|
Retinoblastoma | 1 | 1978 | 318 | 0.010 |
Why?
|
Phylogeny | 1 | 2003 | 2803 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4320 | 0.010 |
Why?
|
Introns | 1 | 1998 | 991 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15519 | 0.010 |
Why?
|
Evoked Potentials | 1 | 1981 | 1056 | 0.010 |
Why?
|
Psychometrics | 1 | 1984 | 3002 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8436 | 0.010 |
Why?
|
Ultrasonography | 1 | 1987 | 5985 | 0.010 |
Why?
|
Granuloma | 1 | 1976 | 319 | 0.010 |
Why?
|
Epithelium | 1 | 1978 | 1679 | 0.010 |
Why?
|
Glioma | 1 | 1988 | 3401 | 0.010 |
Why?
|
Choice Behavior | 1 | 1979 | 803 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1989 | 15076 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 5987 | 0.010 |
Why?
|
Microscopy | 1 | 1978 | 903 | 0.010 |
Why?
|
Prednisone | 1 | 1976 | 1574 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 6171 | 0.010 |
Why?
|
Melanoma | 2 | 1980 | 5510 | 0.010 |
Why?
|
Leukemia | 1 | 1978 | 1511 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1998 | 4328 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1988 | 8863 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1987 | 552 | 0.000 |
Why?
|
Cystathionine | 1 | 1984 | 5 | 0.000 |
Why?
|
Epidemiologic Methods | 2 | 1980 | 1364 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1987 | 20129 | 0.000 |
Why?
|
Biopsy | 1 | 1976 | 6756 | 0.000 |
Why?
|
Accommodation, Ocular | 1 | 1984 | 48 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2009 | 63114 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1976 | 12959 | 0.000 |
Why?
|
West Virginia | 1 | 1980 | 28 | 0.000 |
Why?
|
Growth Disorders | 1 | 1984 | 645 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1987 | 4933 | 0.000 |
Why?
|
Nevus | 1 | 1980 | 204 | 0.000 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 1980 | 349 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1976 | 1827 | 0.000 |
Why?
|
Dogs | 1 | 1976 | 3912 | 0.000 |
Why?
|
Risk | 1 | 1982 | 9687 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1980 | 4851 | 0.000 |
Why?
|
Registries | 1 | 1976 | 8089 | 0.000 |
Why?
|